Next Article in Journal
Feeding Essential Oils to Neonatal Holstein Dairy Calves Results in Increased Ruminal Prevotellaceae Abundance and Propionate Concentrations
Next Article in Special Issue
Epstein–Barr Virus and Innate Immunity: Friends or Foes?
Previous Article in Journal
A Bird’s-Eye View of Chronic Unilateral Conjunctivitis: Remember about Chlamydia psittaci
Previous Article in Special Issue
Extracellular Vesicles in Epstein-Barr Virus’ Life Cycle and Pathogenesis
Open AccessArticle

Efficient Epstein-Barr Virus Progeny Production Mediated by Cancer-Derived LMP1 and Virally-Encoded microRNAs

Division of Microbiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai 983-8536, Japan
Division of Cancer Cell Regulation, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan
Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan
Department of Head and Neck Surgery, Asahi University Hospital, Gifu 500-8523, Japan
Author to whom correspondence should be addressed.
Microorganisms 2019, 7(5), 119;
Received: 26 March 2019 / Revised: 25 April 2019 / Accepted: 28 April 2019 / Published: 30 April 2019
(This article belongs to the Special Issue Recent Advances in Understanding Epstein-Barr Virus)
Epstein-Barr virus (EBV) genomes, particularly their latent genes, are heterogeneous among strains. The heterogeneity of EBV-encoded latent membrane protein 1 (LMP1) raises the question of whether there are functional differences between LMP1 expressed by cancer-associated EBV and that by non-cancerous strains. Here, we used bacterial artificial chromosome (BAC)-cloned EBV genomes retaining all virally encoded microRNA (miRNA) genes to investigate the functions of cancer-derived LMP1 in the context of the EBV genome. HEK293 cells were stably transfected with EBV-BAC clone DNAs encoding either nasopharyngeal carcinoma (NPC)-derived CAO-LMP1 (LMP1CAO) or LMP1 from a prototype B95-8 strain of EBV (LMP1B95-8). When an EBV-BAC clone DNA encoding LMP1CAO was stably transfected into HEK293 cells, it generated many more stable transformants than the control clone encoding LMP1B95-8. Furthermore, stably transfected HEK293 cells exhibited highly efficient production of progeny virus. Importantly, deletion of the clustered viral miRNA genes compromised the ability to produce progeny viruses. These results indicate that cancer-derived LMP1 and viral miRNAs together are necessary for efficient production of progeny virus, and that the resulting increase in efficiency contributes to EBV-mediated epithelial carcinogenesis. View Full-Text
Keywords: Epstein-Barr virus; Nasopharyngeal carcinoma; LMP1; BART; microRNA Epstein-Barr virus; Nasopharyngeal carcinoma; LMP1; BART; microRNA
Show Figures

Graphical abstract

MDPI and ACS Style

Yajima, M.; Miyata, M.; Ikuta, K.; Hasegawa, Y.; Oneyama, C.; Kanda, T. Efficient Epstein-Barr Virus Progeny Production Mediated by Cancer-Derived LMP1 and Virally-Encoded microRNAs. Microorganisms 2019, 7, 119.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop